Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • HealthTech Dialogues
    • VLCC eyes 50 percent...

    VLCC eyes 50 percent business from products in 3 yrs

    Written by savita thakur thakur Published On 2017-08-29T11:55:40+05:30  |  Updated On 29 Aug 2017 11:55 AM IST
    VLCC eyes 50 percent business from products in 3 yrs



    Mumbai: Beauty and wellness firm VLCC is betting big on its products division and expects it to contribute around half of its turnover in the next three years from 35 per cent at present.


    "The product business is certainly one of our growth drivers. We expect an equal share of product business in the next three years," VLCC Healthcare Director Sandeep Ahuja told.


    The firm offers weight loss solutions and beauty treatments. It also retails its products across 1,10,000 outlets.


    The company has been clipping at a CAGR of 16-20 per cent for the last five years and is eyeing a turnover of Rs 1,000 crore this fiscal.


    "We will achieve a turnover of Rs 1,000 crore this year, with 65 per cent from services and 35 per cent from products," he said.


    Its portfolio includes skin care, sun protection, hair care, lip balms and slimming products, among others.


    Non-traditional channels like e-commerce and teleshopping contribute about 10 per cent of sales, with e-commerce constituting a major bulk.


    The Delhi-based company has earmarked Rs 70-80 crore for marketing spends this year.


    VLCC currently operates 200 centres in India and will scale up by 20-25 per cent every year, he said.


    It also has a presence in 13 other countries and operates 50 centres in the overseas market. Ahuja said the company will be adding four to five new centres every year, starting from the calendar year 2018.


    Global market contributes around 30 per cent of the company's total revenues.


    It also plans to get listed on the bourses after having abandoned its plans last year due to poor market sentiment.


    "IPO (initial public offering) is still an item on agenda and we will be looking at that route. When we last filed our DRHP (draft red herring prospectus) it was around Rs 600 crore and I don't think anything less than that will happen but I am not sure about the timing," Ahuja said.



    CAGRproductsprofitSandeep AhujaVLCCVLCC Healthcare
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok